Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Cisco who wrote (1069)	1/11/1998 2:24:00 PM
From: Sigmund	Read Replies (2) \| Respond to of 1894

Anything is possible in science. Hope market is ok Monday. Hope ACMI does not drop. If it does I hope I have the guts to buy more. As NeoPath moves towards approval or deadly rejection, I wonder what the NSIX people are thinking. I find it difficult to see how they are anything but losers in this either way. Some say the NSIX technology is better than NPTH's but their strategy of sending everything to a centralized place to be analyzed adds cost and time. A NSIX/NPTH merger makes some sense. It simplifies things for NPTH and provides the NSIX shareholders with an exit. Sigmund 3 P-KB3